Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol versus Salmeterol on small airway function in COPD (crossover study)
2008-008656-16Phase 4Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of formoterol and salmeterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Lung Reactance X5 (Impulse Oscillometry). Started Oct 2009; status: completed.
02
Drugs
formoterolsalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-008656-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008656-16.